ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,794.70
      -0.55%
      US Tech 100
      20,042.00
      -1.21%
      Dow Jones
      42,064.04
      0.30%
      Brent Oil
      80.635
      0.02%
      Bitcoin
      91,854.39
      -2.79%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Stoke Therapeutics Inc (STOK)

      7. Stoke Therapeutics Inc (STOK) News

      Stoke Therapeutics Inc

      Stoke Therapeutics Inc (STOK)

      NASDAQ
      8.67
      -0.33
      ( -3.67% )
      Updated: 11:21:52
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      STOK News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 07 2025
      STOK (-3.67%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 27 2024
      STOK (-3.67%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      December 23 2024
      STOK (-3.67%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 11 2024
      STOK (-3.67%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 11 2024
      STOK (-3.67%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 10 2024
      STOK (-3.67%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 10 2024
      STOK (-3.67%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      December 09 2024
      STOK (-3.67%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 06 2024
      STOK (-3.67%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 05 2024
      STOK (-3.67%)

      STOK Discussion

      View Posts
      PonkenPlonken PonkenPlonken 2 months ago
      I am so STOKED about this company. They were doing this before they all figured out you need RNA science for gene therapy.
      See SRPT ARWR deal! another AAV based gene tx seeking RNAI
      👍️0
      Monksdream Monksdream 4 months ago
      FOLD under $15
      👍️0
      Zardiw Zardiw 10 months ago
      $STOK Chart from #DDAmanda - #1 Stock Screener :

      Scans are preset. Push a Button. Find Winners Early:



      Z
      👍️0
      TimeFades TimeFades 10 months ago
      Choppy day shoulda just stuck with my morning short
      👍️0
      TimeFades TimeFades 10 months ago
      Got bullish again and covered
      👍️0
      TimeFades TimeFades 10 months ago
      Short from 12s
      👍️0
      Invest-in-America Invest-in-America 10 months ago
      STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
      https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

      Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)
      👍️0

      Your Recent History

      NASDAQ
      STOK
      Stoke Therapeutics
      LSE
      TPVE
      Triple Point Income Vct
      USOTC
      ASKRF
      Asetek A S T Ret (PK)
      TSXV
      VIV.H
      Avivagen
      LSE
      JPSS
      Jpmorgan Japan Small Cap...
      TSXV
      PEX
      Pacific Ridge Exploration
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads